ACG
h.o.l.M.E.S.
Automated Clinical Guidelines
ΨΥΧΗΣ ΙΑΤΡΕΙΟΝ
Antidiabetic Combinations
Duetact adjunct to diet and exercise in type 2 diabetes in patients already on pioglitazone + a sulfonylurea, or in patients on either pioglitazone or a sulfonylurea who need additional glycemic control.
Manufacturer's Website: Not Available Average retail cost: $702/30 tabs
Duetact (glimepiride/pioglitazone)
* Prices reflect U.S. average retail price
Ertugliflozin (trade name Steglatro) is a drug for the treatment of type 2 diabetes. In the United States, it was approved by the Food and Drug Administration for use as a monotherapy and as a fixed--dose combination with either sitagliptin or with metformin....Wikipedia
Manufacturer's Website: Segluromet Average retail cost: $427/60 tabs
Segluromet (ertugliflozin/metformin)
Pioglitazone/metformin (also known by the brand names Actoplus Met, Piomet and Politor) is combination of two oral diabetes medications pioglitazone and metformin. The two oral antihyperglycemic agents with different mechanisms of action are used to improve glycemic control in patients with diabetes mellitus type 2...Wikipedia
Manufacturer's Website: Not Available Average retail cost: $481/30 tabs
ActoPlus Met XR (metformin/pioglitazone)
DPP-4 inhibitors combined with metformin include a sitagliptin/metformin combination and a saxagliptin combination (Komboglyze), and with alogliptin as Kazano among others...Wikipedia
Manufacturer's Website: Kombiglyze Average retail cost: $529/60 tabs
Kombiglyze XR (metformin/saxagliptin)
In 2013 the FDA approved the drug in three formulations: As a stand-alone with the brand-name Nesina. Combined with metformin using the name Kazano, and when combined with pioglitazone as Oseni... Wikipedia
Manufacturer's Website: Not Available Average retail cost: $1,5240/180 tabs
Kazano (alogliptin/metformin)
Sitagliptin/metformin (trade name Janumet) is an anti-diabetic drug, being a combination drug of sitagliptin (a dipeptidyl peptidase-4 inhibitor) and metformin...Wikipedia
Manufacturer's Website: Janumet Average retail cost: $693/60 tabs
Janumet (metformin/sitagliptin)
Like other medications for the treatment of Type 2 diabetes, alogliptin does not decrease the risk of heart attack and stroke. Like other members of the gliptin class, it causes little or no weight gain, exhibits relatively little risk of causing hypoglycemia, and exhibits relatively modest glucose-lowering activity...Wikipedia
Manufacturer's Website: Not Available Average retail cost: $533/30 tabs
Oseni (alogliptin/pioglitazone)
In Europe, Canada, and elsewhere metformin combined with linagliptin is marketed under the trade name Jentadueto...Wikipedia
Manufacturer's Website: Jentadueto Average retail cost: $621/30 tabs
Jentadueto XR (linagliptin/metformin)
In Europe, Canada, and elsewhere metformin combined with linagliptin is marketed under the trade name Jentadueto...Wikipedia
Manufacturer's Website: Jentadueto Average retail cost: $621/60 tabs
Jentadueto (linagliptin/metformin)
In Feb 2017 the FDA approved a once-daily combination of dapagliflozin 10 mg and saxagliptin 5 mg, as Qtern...Wikipedia
Manufacturer's Website: Qtern Average retail cost: $140/6 tabs
Qtern (dapagliflozin/saxagliptin)
Sitagliptin/metformin (trade name Janumet) is an anti-diabetic drug, being a combination drug of sitagliptin (a dipeptidyl peptidase-4 inhibitor) and metformin...Wikipedia
Manufacturer's Website: Janumet Average retail cost: $695/60 tabs
Janumet XR (metformin/sitagliptin)
Ertugliflozin (trade name Steglatro) is a drug for the treatment of type 2 diabetes. In the United States, it was approved by the Food and Drug Administration for use as a monotherapy and as a fixed dose combination with either sitagliptin or with metformin. A combination with metformin is marketed as Segluromet and a combination with sitagliptin is marketed as Steglujan. ...Wikipedia
Manufacturer's Website: Steglujan Average retail cost: $651/30 tabs
Steglujan (metformin/ertugliflozin)
Dapagliflozin is a drug of the gliflozin class, used to treat type 2 diabetes...Wikipedia
Manufacturer's Website: Xigduo Average retail cost: $690/60 tabs
Xigduo XR (dapagliflozin/metformin)
Sitagliptin/metformin (trade name Janumet) is an anti-diabetic drug, being a combination drug of sitagliptin (a dipeptidyl peptidase-4 inhibitor) and metformin...Wikipedia
Manufacturer's Website: Janumet Average retail cost: $695/60 tabs
Janumet XR (metformin/sitagliptin)
Ertugliflozin (trade name Steglatro) is a drug for the treatment of type 2 diabetes. In the United States, it was approved by the Food and Drug Administration for use as a monotherapy and as a fixed dose combination with either sitagliptin or with metformin. A combination with metformin is marketed as Segluromet and a combination with sitagliptin is marketed as Steglujan. ...Wikipedia
Manufacturer's Website: Steglujan Average retail cost: $651/30 tabs
Steglujan (metformin/ertugliflozin)
Dapagliflozin is a drug of the gliflozin class, used to treat type 2 diabetes...Wikipedia
Manufacturer's Website: Xigduo Average retail cost: $690/60 tabs
Xigduo XR (dapagliflozin/metformin)
Synjardy (empagliflozin and metformin) is used to lower blood sugar and treat type 2 diabetes.
Manufacturer's Website: Synjardy Average retail cost: $768/60 tabs
Synjardy XR (empagliflozin/metformin)
Canagliflozin (trade name Invokana or Sulisent) is a medication used for the treatment of type 2 diabetes. It is of the gliflozin class or subtype 2 sodium-glucose transport (SGLT-2) inhibitors class...Wikipedia
Manufacturer's Website: Invokamet Average retail cost: $708/60 tabs
Invokamet (canagliflozin/metformin)
Empagliflozin/linagliptin is a drug combination used for the treatment of type II diabetes. It is a combination of empagliflozin and linagliptin. The combination preparation was developed and is marketed by Boehringer Ingelheim and Eli Lilly under the trade name Glyxambi...Wikipedia
Manufacturer's Website: Glyxambi Average retail cost: $723/30 tabs
Glyxambi (empagliflozin/linagliptin)
Pioglitazone/metformin (also known by the brand names Actoplus Met, Piomet and Politor) is combination of two oral diabetes medications pioglitazone and metformin. The two oral antihyperglycemic agents with different mechanisms of action are used to improve glycemic control in patients with diabetes mellitus type 2...Wikipedia
Manufacturer's Website: Not Available Average retail cost: $636/60 tablets
ActoPlus Met (metformin/pioglitazone)
Insulin glargine/lixisenatide is a combination drug that combines insulin glargine and lixisenatide and is used as second-line treatment for diabetes...Wikipedia
Manufacturer's Website: Soliqua Average retail cost: $1,052/carton
Soliqua (insulin glargine/lixisenatide)
Insulin glargine/lixisenatide is a combination drug that combines insulin glargine and lixisenatide and is used as second-line treatment for diabetes...Wikipedia
Manufacturer's Website: Xultophy Average retail cost: $1,529/5 pens
Xultophy (insulin degludec/liraglutide)
Empagliflozin/linagliptin/metformin, sold under the brand name Trijardy XR, is a drug combination used for the treatment of type 2 diabetes. It is a combination of empagliflozin, linagliptin, and metformin. Empagliflozin/linagliptin/metformin was approved for use in the United States in January 2020....Wikipedia
Manufacturer's Website: TrijardyXR Average retail cost: $723/60 tabs
Trijardy XR (Empagliflozin/linagliptin/metformin)
Synjardy (empagliflozin and metformin) is used to lower blood sugar and treat type 2 diabetes.
Manufacturer's Website: Synjardy Average retail cost: $364/30 tabs
Synjardy (empagliflozin/metformin)
Canagliflozin (trade name Invokana or Sulisent) is a medication used for the treatment of type 2 diabetes. It is of the gliflozin class or subtype 2 sodium-glucose transport (SGLT-2) inhibitors class...Wikipedia
Manufacturer's Website: Invokamet Average retail cost: $708/60 tabs
Invokamet XR (canagliflozin/metformin)
